# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-20-007650
Filing Date
2020-03-27
Accepted
2020-03-27 15:22:51
Documents
99
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2019_immucellcorp.htm | 10-K | 904600
2 | +FORM OF INCENTIVE STOCK OPTION AGREEMENT | f10k2019ex10-9_immucell.htm | EX-10.9 | 16489
3 | SEVERANCE AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATED AS OF MARCH | f10k2019ex10-20_immucell.htm | EX-10.20 | 64704
4 | AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BO | f10k2019ex10-21_immucell.htm | EX-10.21 | 11824
5 | CONSENT OF WIPFLI LLP | f10k2019ex23-1_immucell.htm | EX-23.1 | 3506
6 | CONSENT OF RSM US LLP | f10k2019ex23-2_immucell.htm | EX-23.2 | 3670
7 | CERTIFICATION | f10k2019ex31_immucell.htm | EX-31 | 9039
8 | CERTIFICATION | f10k2019ex32_immucell.htm | EX-32 | 5733
| Complete submission text file | 0001213900-20-007650.txt |  | 5163874

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | iccc-20191231.xml | EX-101.INS | 813689
10 | XBRL SCHEMA FILE | iccc-20191231.xsd | EX-101.SCH | 61328
11 | XBRL CALCULATION FILE | iccc-20191231_cal.xml | EX-101.CAL | 70936
12 | XBRL DEFINITION FILE | iccc-20191231_def.xml | EX-101.DEF | 182733
13 | XBRL LABEL FILE | iccc-20191231_lab.xml | EX-101.LAB | 462669
14 | XBRL PRESENTATION FILE | iccc-20191231_pre.xml | EX-101.PRE | 356060

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 20751228
SIC: 2835 In Vitro & In Vivo Diagnostic Substances